STORM in the News
STORM Therapeutics featured in BioIndustry Association Report which highlights the Company's Series A financing as one of the top 15 UK venture rounds of 2019.
Read more
Following the STORM RNA epigenetics conference in Cambridge, UK on 17-19 September, STORM's Chief Scientific Officer, Oliver Rausch writes on the role of RNA epigenetics in medicine for the November-December 2019 edition of MedNous, a publication of Evernow Publishing Ltd.
Read more
CEO Keith Blundy spoke to WuXi AppTec for the newly released White Paper on RNA therapeutics.
Read more
Allison Johnson spoke to STORM about how a new quantitative method could help RNA epigenetics companies
Read more
Clara Rodríguez Fernández spoke with Keith Blundy, CEO STORM Therapeutics and Hakan Goker, M Ventures about leading the development of the first treatments to target a new layer of genetic information encoded in the RNA.
Read more